Tuesday, September 22, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $338.98 +0.85%
MSFT $501.61 +1.59%
GOOGL $354.97 +1.55%
AMZN $258.45 +1.87%
TSLA $375.30 +3.03%
META $741.25 +11.34%
NVDA $227.38 +2.30%
JPM $352.04 +0.68%
BTC $38.25 +6.52%
ETH $26.36 +4.69%
Latest Signing ceremony for contribution agreements between WHO and France Oct 17, 2024
AAPL
$338.98
▲ 0.85%
MSFT
$501.61
▲ 1.59%
GOOGL
$354.97
▲ 1.55%
AMZN
$258.45
▲ 1.87%
TSLA
$375.30
▲ 3.03%
META
$741.25
▲ 11.34%
NVDA
$227.38
▲ 2.30%
JPM
$352.04
▲ 0.68%

Top Stories

Markets →
All Markets Technology Economy Science Health Sports Entertainment Politics
Bloomberg Markets
Mike Wilson Says Oil Risk to Equities Not Insurmountable
Mike Wilson, chief investment officer and chief US equity strategist at Morgan Stanley, discusses how markets have “digested” multiple risks through the year and says the firm is rotating instead of reducing their overall exposure to equities. Wilson also warns about concerns in the short term for stocks related to crude product prices. (Source: Bloomberg)
business  Sep 9, 2026
Science Daily
Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study. It was also associated with about 20% fewer COPD flare-ups. Researchers say GLP-1 drugs may offer respiratory benefits in addition to their effects on diabetes and obesity, but clinical trials are needed to confirm the findings.
science  Sep 9, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free